Research News

  • NIH Awards $20M to UVM and Maine Medical Center To Address Rural Health Challenges
    A five-year, $20 million National Institutes of Health (NIH) Clinical and Translational Research (CTR) Network grant will fund a joint program between the University of Vermont (UVM) and Maine Medical Center in Portland, Maine to develop and sustain a clinical and translational research infrastructure improving rural and community health for residents of Vermont, New Hampshire and Maine.
  • Botten Leads One of Two Innovative Research Teams Awarded 2017 UVM SPARK-VT Grants
    Two University of Vermont research teams have been awarded SPARK-VT grants by the university to help commercialize their work and move it a step closer to the marketplace, following a faculty pitch competition held June 16, 2017.
  • Stapleton Co-Leads Innovative ICU Recovery Study
    For patients who survive an episode of critical illness, they can experience weakness and other limitations to their function long after they’ve left the hospital. But there’s hope in sight: A unique, multi-site clinical trial that aims to improve outcomes for intensive care unit patients using a combination of early nutritional supplementation and exercise.
  • Lyon Leads Trial to Test Vaccine Aimed to Protect Military Troops
    Acute respiratory disease (ARD) due to infection with adenovirus is a major cause of morbidity at military training centers. In addition to ARD, adenovirus infection can cause sore throat, pneumonia, conjunctivitis, and urinary infections.
  • Electrical “switch” in brain’s capillary network monitors activity and controls blood flow
    All it takes is the flip of a protein “switch” within the tiny wire-like capillaries of the brain to increase the blood flow that ensures optimal brain function. New research has uncovered that capillaries have the capacity to both sense brain activity and generate an electrical vasodilatory signal to evoke blood flow and direct nutrients to nourish hard-working neurons.
  • Vaping and Withdrawal: Study to Explore Body’s Response to Quitting E-Cigs
    While the debate regarding the safety of e-cigarettes continues, another issue has emerged: Is vaping addictive?
  • Novel Dimensional Approach Uncovers Biomarker for Inattention
    Despite diagnoses for attention-deficit/hyperactivity disorder (ADHD) occurring in a reported 11 percent of U.S. school-aged kids, clinicians still don’t fully understand the underlying causes of this common condition. Now a brain marker may be on the horizon, thanks to a new approach that provides evidence of a relationship between brain structure and dimensional measures of ADHD symptoms.
  • Stressed Out Interferons Reveal Potential Key to Alternative Lupus Treatment
    Only one new drug has become available over the past 50 years for the estimated 1.5 million Americans and five million-plus people worldwide suffering from lupus, but new research has identified a previously unknown mechanism involved in the immune response that could provide an alternative therapy target.
  • American Heart Month: Zakai Research Q&A on Populations Most at Risk for Vascular Disease
    The following interview with Neil Zakai, M.D., M.Sc., associate professor of medicine at the Larner College of Medicine at the University of Vermont, originally appeared on the Facebook page of the Thrombosis and Haemostasis journal and focused on his research publication, titled “D-dimer and the Risk of Stroke and Coronary Heart Disease: The REasons for Geographic and Racial Differences in Stroke (REGARDS),” which was pre-published online in December 2016. (Key: TH = Thrombosis and Haemostasis; NZ = Neil Zakai)
  • Littenberg & Chopan’s Study Finds Association between Eating Hot Peppers and Decreased Mortality
    Like spicy food? If so, you might live longer, say researchers at the Larner College of Medicine at the University of Vermont, who found that consumption of hot red chili peppers is associated with a 13 percent reduction in total mortality – primarily in deaths due to heart disease or stroke – in a large prospective study.